See also this year's filing and all EDGAR filings for this company.
PDF Report 0000894158_2024_Theriva_Biologics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Calc2)': 2, '00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 11}} |
Graph
Absolute values for 0000894158, Theriva Biologics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 27,403,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 25,455,000 |
| 2 | PropertyPlantAndEquipmentNet | 422,000 |
| 3 | remainder_Assets | 1,939,000 |
| 4 | LiabilitiesCurrent | 6,738,000 |
| 5 | LiabilitiesNoncurrent | 2,348,000 |
| 6 | remainder_Liabilities | 6,436,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,463,314 |
| 9 | ResearchAndDevelopmentExpense | 16,123,812 |
| 10 | remainder_Expenses | -1,678,199 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,305,309 |
| 13 | remainder_ComprehensiveNetIncome | -666,386 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 55,219,000 |
| 1 | Liabilities | 15,522,000 |
| 2 | Expenses | 20,908,927 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 39,697,000 |
| 5 | NetIncome | -19,603,618 |
| 6 | ComprehensiveNetIncome | -19,936,811 |
| 7 | BaseVar | 46,810,811 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.88 |
| 9 | EconomicCapitalRatio | 2.95 |
Edgar->Model Mapping
Feature Distribution
Change over Time
